KULKARNI SAMARTH

PrivateCIK: 1682019
Location

CAMBRIDGE, MA

Senior insider sale

Chief Executive Officer at CRISPR THERAPEUTICS AG — senior position signals high conviction

$1.58M

30K shares

What this filing means

KULKARNI SAMARTH plans to sell 30K shares of CRISPR THERAPEUTICS AG valued at approximately $1.58M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.

InsiderKULKARNI SAMARTHCIK 1682019
IssuerCRISPR THERAPEUTICS AGCIK 1674416
DirectorOfficer· Chief Executive Officer
Since Sep 2018
30K
Shares to sell
$1.58M
Approx. market value
30K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months11
Sort

Acquired as compensation -- Restricted Stock Awards

Compensation

10/16/2025
1.02K

Acquired as compensation -- Restricted Stock Awards

Compensation

10/12/2025
4.09K

Acquired as compensation -- Restricted Stock Awards

Compensation

3/11/2024
4.42K

Acquired as compensation -- Restricted Stock Awards

Compensation

3/10/2024
4.87K

Acquired as compensation -- Restricted Stock Awards

Compensation

3/9/2024
1.66K

Acquired as compensation -- Restricted Stock Awards

Compensation

3/6/2024
2.92K

Acquired as compensation -- Restricted Stock Awards

Compensation

2/17/2024
3.43K

Acquired as compensation -- Restricted Stock Awards

Compensation

2/15/2024
3.45K

Acquired as compensation -- Restricted Stock Awards

Compensation

12/3/2022
2.29K

Acquired as compensation -- Restricted Stock Awards

Compensation

9/1/2018
926.00

Acquired as compensation -- Restricted Stock Awards

Compensation

6/1/2018
926.00
Total acquired30K
Planned & Completed Dispositions1
Sort
NASDPlanned

Units to sell

30K

Market value

$1.58M

1/20/2026
Total

Units

30K

Value

$1.58M

KULKARNI SAMARTH — Planned Insider Sale (Form 144) | Finecho